| 标题 |
 A phase IIb dose‐ranging study of the oral JAK inhibitor tofacitinib (CP‐690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone |
| 网址 | |
| DOI | |
| 其它 |
期刊：Arthritis & Rheumatism 作者：Joel M. Kremer; Stanley Cohen; Bethanie E. Wilkinson; Carol A. Connell; Jonathan L. French; et al 出版日期：2011-10-17 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时，文件已从服务器自动删除，无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
GingerF
GG
OK
arniu2008
Nexus
Samuel
Nole
cdercder
嘻嘻哈哈
Criminology34
liuzhuohao
fantasy
sagitar
行走的荷尔蒙
时尚梦易
Oracle
lx
初景
Copyright
皖公网安备34019202002308
